Alfuzosin
Also known as: Alfuzosin hydrochloride
Brand names: ALFURAL RANFUZOSIN UROXATRAL XATRAL
Therapeutic Indications
Alfuzosin is indicated for:
Benign prostatic hypertrophy (BPH)
Men inly, only Adults (18 years old or older)
Treatment of the functional symptoms of benign prostatic hypertrophy (BPH).
For this indication, the medical literature mentions below treatments (click for details):
Treatment 1: Oral - 10mg once daily
Contraindications
Active ingredient Alfuzosin is contraindicated in the following cases:
Alpha-1 receptor blockers
No gender/age discrimination
Combination with other alpha-1 receptor blockers.
Orthostatic hypotension
No gender/age discrimination